Related Experiment Video
Updated: May 8, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Difficulties in diagnosing neuroleptic malignant syndrome
Monica S Zolezzi1, Abdullah M Al-Hathloul
1Department of Pharmaceutical Services, Armed Forces Hospital, PO Box 7897, Riyadh 11159, Kingdom of Saudi Arabia. Tel/Fax. +966 (1) 4777714 Ext. 3432.
Abstract:
This report describes a recent case of neuroleptic malignant syndrome, a rare adverse effect of antipsychotic medications. Assessment of the neuroleptic malignant syndrome was carried out by using the Naranjo Algorithm Probability Scale which resulted in a highly probable reaction to haloperidol. The difficulties in establishing the diagnosis in this patient lead to late intervention resulting in a slow recovery and prolonged hospitalization. Our objective in this presentation is to highlight the importance of early recognition of this potentially fatal adverse drug reaction.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Alterations in Muscle Tone lll
Psychosis: Goals of Pharmacotherapy
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
